Tnp+ Opposition, Pembrolizumab [Keytruda], (Th1901006941, Wo/2021/250648, Pct/Ib2021/057281)
No Annotations
Alert me when there are new annotations for this document
4 similar patent oppositions
-
TNP+ opposition, Nirmatrelvir/Ritonavir [Paxlovid], (TH2101007038, WO/2021/250648, PCT/IB2021/057281)
Countries: Thailand Date: 2026
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Delamanid, (PCT/JP2019/023006)
Countries: Thailand Date: 2026
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, MK-8527, (TH1601005648, WO2015143712A1, PCT/CN2014/074294)
Countries: Thailand Date: 2026
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Bedaquiline, (TH1901005409, WO/2018/158280, PCT/EP2018/054860)
Countries: Thailand Date: 2026